The goal of this pilot study is to determine if the pharmacokinetics of vincristine and its metabolite M1 will differ between young children and Adolescents and Young Adults as defined by Tanner stage. Additionally, we want to evaluate calpain as a marker for neurotoxicity.

NIH Funding Acknowledgment: Important - All publications resulting from the utilization of SC CTSI resources are required to credit the SC CTSI grant by including the NIH funding acknowledgment and must comply with the NIH Public Access Policy.